Sodium Glucose Co-Transporter 2 Inhibition Does Not Favorably Modify the Physiological Responses to Dietary Counselling in Diabetes-Free, Sedentary Overweight and Obese Adult Humans

Sedentary obesity is associated with increased risk of many cardio-metabolic diseases, including type 2 diabetes. Weight loss is therefore a desirable goal for sedentary adults with obesity. Weight loss is also a well-documented side effect of sodium glucose co-transporter 2 (SGLT2) inhibition, a ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryan, Shane P.P., Newman, Alissa A., Wilburn, Jessie R., Rhoades, Lauren D., Trikha, S. Raj J., Godwin, Ellen C., Schoenberg, Hayden M., Battson, Micah L., Ewell, Taylor R., Luckasen, Gary J., Biela, Laurie M., Melby, Christopher L., Bell, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071188/
https://www.ncbi.nlm.nih.gov/pubmed/32085394
http://dx.doi.org/10.3390/nu12020510

Ejemplares similares

Ejemplares similares